Perceptive Advisors - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 106 filers reported holding STOKE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.7%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$45,238,000
+73.3%
1,343,956
+100.0%
0.29%
-10.9%
Q1 2021$26,100,000
-37.3%
671,9780.0%0.33%
-26.2%
Q4 2020$41,616,000
+84.9%
671,9780.0%0.45%
+35.9%
Q3 2020$22,505,000
+40.5%
671,9780.0%0.33%
+27.0%
Q2 2020$16,013,000
+4.1%
671,9780.0%0.26%
-35.4%
Q1 2020$15,388,000
-19.1%
671,9780.0%0.40%
+6.1%
Q4 2019$19,030,000
+31.8%
671,9780.0%0.38%
-2.8%
Q3 2019$14,440,000
-26.3%
671,9780.0%0.39%
-13.6%
Q2 2019$19,601,000671,9780.45%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Skorpios Trust 14,443,681$56,908,10399.78%
Lynx1 Capital Management LP 1,710,154$6,738,0074.46%
COWEN AND COMPANY, LLC 3,721,659$14,663,3361.03%
Redmile Group, LLC 3,872,696$15,258,4220.73%
RTW INVESTMENTS, LP 4,390,558$17,298,7990.36%
Birchview Capital, LP 85,000$334,9000.28%
Cormorant Asset Management, LP 1,087,807$4,285,9600.25%
Granahan Investment Management 851,201$3,353,7320.12%
GSA CAPITAL PARTNERS LLP 348,069$1,3710.12%
Simplify Asset Management Inc. 102,985$405,7610.05%
View complete list of STOKE THERAPEUTICS INC shareholders